• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 564-578 of 973 results

3001 Exhibit: Exhibit 3001

Document IPR2023-00724, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Aug. 3, 2023)

cite Cite Document
Analyze

2072 Exhibit: EX2072 Ozempic® Prescribing Information December 2017

Document IPR2023-00724, No. 2072 Exhibit - EX2072 Ozempic® Prescribing Information December 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2383 Exhibit: EX2383 Bishop, S, “Losing Weight Can Have Big Impact on Those Wit...

Document IPR2023-00724, No. 2383 Exhibit - EX2383 Bishop, S, “Losing Weight Can Have Big Impact on Those With Diabetes,” httpsnewsnetworkmayoclinicorgdiscussionlosing weight can have big impa...

cite Cite Document
Analyze

2424 Exhibit: EX2424 US Food Drug Administration, DrugsFDA, Jentadueto® XR

Document IPR2023-00724, No. 2424 Exhibit - EX2424 US Food Drug Administration, DrugsFDA, Jentadueto® XR (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2450 Exhibit: EX2450 Glyxambi Prescribing Information rev Dec 2017

Document IPR2023-00724, No. 2450 Exhibit - EX2450 Glyxambi Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2552 Exhibit: EX2552 Transcript of July 11, 2024 Deposition of John Bantle, MD

Document IPR2023-00724, No. 2552 Exhibit - EX2552 Transcript of July 11, 2024 Deposition of John Bantle, MD (P.T.A.B. Jul. 31, 2024)

cite Cite Document
Analyze

2362 Exhibit: EX2362 US Food Drug Administration, DrugsFDA, Diabeta®

Document IPR2023-00724, No. 2362 Exhibit - EX2362 US Food Drug Administration, DrugsFDA, Diabeta® (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2530 Exhibit: EX2530 Janumet XR Prescribing Information rev Feb 2012

Document IPR2023-00724, No. 2530 Exhibit - EX2530 Janumet XR Prescribing Information rev Feb 2012 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

3002 Exhibit: Exhibit 3002

Document IPR2023-00724, No. 3002 Exhibit - Exhibit 3002 (P.T.A.B. Nov. 29, 2023)

cite Cite Document
Analyze

2439 Exhibit: EX2439 Jardiance® Prescribing Information rev Dec 2017

Document IPR2023-00724, No. 2439 Exhibit - EX2439 Jardiance® Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2083 Exhibit: EX2083 V Aroda et al, “Efficacy and safety of once weekly semaglutid...

Document IPR2023-00724, No. 2083 Exhibit - EX2083 V Aroda et al, “Efficacy and safety of once weekly semaglutide versus once daily insulin glargine as add on to metformin with or without sulfonylureas...

cite Cite Document
Analyze

2300 Exhibit: EX2300 Declaration of Christopher A Vellturo, PhD REDACTED

Document IPR2023-00724, No. 2300-2 Exhibit - EX2300 Declaration of Christopher A Vellturo, PhD REDACTED (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2458 Exhibit: EX2458 US Food Drug Administration, DrugsFDA, Soliqua 10033

Document IPR2023-00724, No. 2458 Exhibit - EX2458 US Food Drug Administration, DrugsFDA, Soliqua 10033 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2488 Exhibit: EX2488 US Patent No 8,536,122

Document IPR2023-00724, No. 2488 Exhibit - EX2488 US Patent No 8,536,122 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2049 Exhibit: EX2049 Declaration of Devraj Chakravarty

Document IPR2023-00724, No. 2049 Exhibit - EX2049 Declaration of Devraj Chakravarty (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 38 39 40 41 42 ... >>